Patents by Inventor Anat David

Anat David has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040219583
    Abstract: The invention concerns novel nucleic acid sequences, amino acid sequences coded thereby and method of detection using the above. The novel nucleic acid sequences are naturally occurring splice variants of a prostate specific antigen sequence (PSA) or of the KLK-2 gene.
    Type: Application
    Filed: March 16, 2004
    Publication date: November 4, 2004
    Applicant: Compugen Ltd.
    Inventors: Kinneret Savitzky, Liat Mintz, Anat David, Idit Azar
  • Patent number: 6740516
    Abstract: An isolated nucleic acid sequence depicted in SEQ ID NO:6 is an alternative splice variant of human kallikrien-2 gene (KLK-2). An expression vector containing the splice variant and a host cell transfected by the expression vector are provided. The nucleic acid is useful for determining the level of nucleic acid sequences of human kallikrien variants in a biological sample.
    Type: Grant
    Filed: January 8, 2001
    Date of Patent: May 25, 2004
    Assignee: Compugen Ltd.
    Inventors: Kinneret Savitzky, Liat Mintz, Anat David, Idit Azar
  • Publication number: 20030207808
    Abstract: The invention concerns novel nucleic acid sequences, amino acid sequences coded thereby and method of detection using the above. The novel nucleic acid sequences are naturally occurring splice variants of a prostate specific antigen sequence (PSA) or of the KLK-2 gene.
    Type: Application
    Filed: November 19, 2002
    Publication date: November 6, 2003
    Inventors: Kinneret Savitzky, Liat Mintz, Anat David, Idit Azar
  • Publication number: 20020099189
    Abstract: The invention concerns novel nucleic acid sequences, amino acid sequences coded thereby and method of detection using the above. The novel nucleic acid sequences are naturally occurring splice variants of a prostate specific antigen sequence (PSA) or of the KLK-2 gene.
    Type: Application
    Filed: January 8, 2001
    Publication date: July 25, 2002
    Inventors: Kinneret Savitzky, Liat Mintz, Anat David, Idit Azar
  • Publication number: 20020086384
    Abstract: The present invention concerns a plurality of variant nucleic acid and amino acid sequences obtained by alternative splicing of known genes which have been reported in the literature as being involved with tumors. The present invention further concerns a method for detecting said nucleic acid and amino acid sequences, for example, for diagnostic purposes, especially for detection of cancer, predisposition to cancer or evaluation of cancer state.
    Type: Application
    Filed: March 13, 2001
    Publication date: July 4, 2002
    Inventors: Zurit Levine, Anat David, Cobby Romano, Jeanne Bernstein